Deep Track Capital »

Korro Bio shares owned by Deep Track Capital

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $26M 771k 33.87

More positions owned by Deep Track Capital

Amgen (AMGN)
Argenx Se Sponsored Adr (ARGX)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Springworks Therapeutics (SWTX)
Insmed Com Par $.01 (INSM)
Guardant Health (GH)
Dynavax Technologies Corp Com New (DVAX)
Alnylam Pharmaceuticals (ALNY)
Intellia Therapeutics (NTLA)
Intra Cellular Therapies (ITCI)
Apellis Pharmaceuticals (APLS)
Ionis Pharmaceuticals (IONS)
Ocular Therapeutix (OCUL)
4d Molecular Therapeutics In (FDMT)

View all positions for Deep Track Capital

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Deep Track Capital
Citadel Advisors
Vanguard Group
BlackRock
Point72 Asset Management
Siren
BlackRock
Eventide Asset Management
Qiming U.S. Ventures Management
72 Investment Holdings
Cormorant Asset Management
Driehaus Capital Management
Schonfeld Strategic Advisors

View all funds holding Korro Bio